These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30149993)

  • 21. Apical Node Involvement Does Not Influence Prognosis After Potentially Curative Resection for Stage III Colorectal Cancer: A Competing Risks Analysis.
    Ng KS; Dent OF; Chan C; Newland RC; Keshava A; Stewart P; Rickard MJFX; Chapuis PH
    Ann Surg; 2022 Jul; 276(1):e24-e31. PubMed ID: 33074895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synchronous polyps predict metachronous colorectal lesions after curative resection of colorectal cancer.
    Pozza A; Ruffolo C; Fiorot A; Padoan L; Erroi F; Massani M; Caratozzolo E; Bonariol L; Ferrara F; Norberto L; Castoro C; Bassi N; Scarpa M
    Acta Chir Belg; 2016 Aug; 116(4):225-230. PubMed ID: 27426670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colorectal Cancer, Systemic Inflammation, and Outcome: Staging the Tumor and Staging the Host.
    Park JH; Watt DG; Roxburgh CS; Horgan PG; McMillan DC
    Ann Surg; 2016 Feb; 263(2):326-36. PubMed ID: 25575264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time to local recurrence as a prognostic factor in patients with rectal cancer.
    Westberg K; Palmer G; Johansson H; Holm T; Martling A
    Eur J Surg Oncol; 2015 May; 41(5):659-66. PubMed ID: 25749391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colorectal cancer recurrence and its impact on survival after curative surgery: An analysis based on multistate models.
    Balboa-Barreiro V; Pértega-Díaz S; García-Rodríguez T; González-Martín C; Pardeiro-Pértega R; Yáñez-González-Dopeso L; Seoane-Pillado T
    Dig Liver Dis; 2024 Jul; 56(7):1229-1236. PubMed ID: 38087671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic Impact of Histologic Type in Curatively Resected Stage IV Colorectal Cancer: A Japanese Multicenter Retrospective Study.
    Shibata J; Kawai K; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Hata K; Nozawa H; Kazama S; Yamaguchi H; Ishihara S; Sunami E; Kitayama J; Sugihara K; Watanabe T
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S621-9. PubMed ID: 26350364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative anaemia and perioperative red blood cell transfusion as prognostic factors for recurrence and mortality in colorectal cancer-a Swedish cohort study.
    Mörner ME; Edgren G; Martling A; Gunnarsson U; Egenvall M
    Int J Colorectal Dis; 2017 Feb; 32(2):223-232. PubMed ID: 27770250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Major postoperative complications following elective resection for colorectal cancer decrease long-term survival but not the time to recurrence.
    Odermatt M; Miskovic D; Flashman K; Khan J; Senapati A; O'Leary D; Thompson M; Parvaiz A
    Colorectal Dis; 2015 Feb; 17(2):141-9. PubMed ID: 25156234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aggressive colorectal carcinoma phenotypes of invasion can be assessed reproducibly and effectively predict poor survival: interobserver study and multivariate survival analysis of a prospectively collected series of 299 patients after potentially curative resections with long-term follow-up.
    Wöhlke M; Schiffmann L; Prall F
    Histopathology; 2011 Nov; 59(5):857-66. PubMed ID: 22092397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic implications of serum microRNA-21 in colorectal cancer.
    Menéndez P; Padilla D; Villarejo P; Palomino T; Nieto P; Menéndez JM; Rodríguez-Montes JA
    J Surg Oncol; 2013 Nov; 108(6):369-73. PubMed ID: 23970420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in pathology and long-term outcomes after resection of colorectal cancer: 1971-2013.
    Dent OF; Newland RC; Chan C; Bokey L; Chapuis PH
    ANZ J Surg; 2017 Jan; 87(1-2):34-38. PubMed ID: 27647676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgery for colorectal cancer in elderly patients: how can we improve outcome?
    Mothes H; Bauschke A; Schuele S; Eigendorff E; Altendorf-Hofmann A; Settmacher U
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1879-1889. PubMed ID: 28534171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative platelet count associates with survival and distant metastasis in surgically resected colorectal cancer patients.
    Wan S; Lai Y; Myers RE; Li B; Hyslop T; London J; Chatterjee D; Palazzo JP; Burkart AL; Zhang K; Xing J; Yang H
    J Gastrointest Cancer; 2013 Sep; 44(3):293-304. PubMed ID: 23549858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
    Stanisavljević L; Myklebust MP; Leh S; Dahl O
    Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Competing risks analysis of microsatellite instability as a prognostic factor in colorectal cancer.
    Toh J; Chapuis PH; Bokey L; Chan C; Spring KJ; Dent OF
    Br J Surg; 2017 Aug; 104(9):1250-1259. PubMed ID: 28401534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for recurrence in stage II/III colorectal cancer patients treated with curative surgery: The impact of postoperative tumor markers and an infiltrative growth pattern.
    Tokodai K; Narimatsu H; Nishida A; Takaya K; Hara Y; Kawagishi N; Hashizume E; Ohuchi N
    J Surg Oncol; 2016 Sep; 114(3):368-74. PubMed ID: 27264681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic follow-up after curative surgery for colorectal cancer in Norway: a population-based audit of effectiveness, costs, and compliance.
    Körner H; Söreide K; Stokkeland PJ; Söreide JA
    J Gastrointest Surg; 2005 Mar; 9(3):320-8. PubMed ID: 15749591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term outcomes after treatment for T1 colorectal carcinoma.
    Asayama N; Oka S; Tanaka S; Ninomiya Y; Tamaru Y; Shigita K; Hayashi N; Egi H; Hinoi T; Ohdan H; Arihiro K; Chayama K
    Int J Colorectal Dis; 2016 Mar; 31(3):571-8. PubMed ID: 26689400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative Neutrophil-to-Lymphocyte Ratio is a Better Prognostic Serum Biomarker than Platelet-to-Lymphocyte Ratio in Patients Undergoing Resection for Nonmetastatic Colorectal Cancer.
    Choi WJ; Cleghorn MC; Jiang H; Jackson TD; Okrainec A; Quereshy FA
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S603-13. PubMed ID: 25900206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor Diameter is an Easy and Useful Predictor of Recurrence in Stage II Colorectal Cancer.
    Maeda C; Hidaka E; Mori Y; Mukai S; Miyachi H; Sawada N; Ishida F; Kudo SE
    Dig Surg; 2015; 32(5):338-43. PubMed ID: 26183549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.